|Previous Section||Index||Home Page|
Mr. Hoon: The Government have now approved the procurement of Type 45 destroyers, in line with our firm commitment to a modern and effective destroyer and frigate force. Subject to the satisfactory completion of negotiations, a contract will be placed later this year with the prime contractor, BAe Systems, for the first three of these ships, and including some major long-lead equipment for a further three, at an estimated cost in excess of £1 billion. It is planned that the first and third ships will be assembled by BAe Systems Marine, and the second ship by Vosper Thornycroft. The first of class is expected to be launched from the BAe Systems Marine Scotstoun yard on the Clyde.
The class is to be named the 'D' Class and Her Majesty the Queen has graciously agreed to the first of class being named HMS Daring and the second HMS Dauntless. This revives two names that have served the Royal Navy well since the early 1800s.
The ships will be equipped with the PAAMS Anti Air Missile System, a collaborative programme with France and Italy, and will provide highly effective area defence against aircraft and missiles. In addition, the Type 45 Destroyer will be a multi-role, general purpose platform capable of operations across the spectrum of tasks from peace support to high intensity warfare.
12 Jul 2000 : Column: 572W
Dr. Moonie [pursuant to his reply, 7 June 2000, c. 237W]: I must apologise that my answer contained an erroneous figure for Key Target 2. The figure for average cumulative slippage of in-service dates at 31 March 2001 should have read 23.8 months, rather than the 20.9 months shown in the Official Report.
Mr. Gardiner: To ask the Secretary of State for Health how many district nurses working for Parkside Community Health Trust who carry a clinical case load have been given discretionary award points under the recommendations of the pay review body in 1998. 
Mr. Denham: In line with national guidance from National Health Service Executive, Parkside Health NHS Trust has developed guidelines for awarding discretionary points to its nursing and therapy staff. This was done in consultation with staff groups and their representatives. The trust has considered a total of 59 applications, of which 30 were successful. Of these, six applications came from district nurses, and two were given discretionary award points.
However, they do not produce population data below these levels, which includes population by trusts. Currently, the only population data available below health authority and local authority districts are ward level data, which are based on the 1991 Census.
Mrs. Virginia Bottomley: To ask the Secretary of State for Health what assessment he has made of the commitments given by the West Surrey Health Authority Chief Executive and the Chief Executive of the Surrey Hampshire Borders Trust concerning the future of community beds at Farnham Hospital in the "Right Balance" plans published in May 1998 . 
Mr. Denham: It is for local health authorities to decide on the configuration of services that best suit their local health economy's needs, based on the specialised knowledge they have of the local community.
12 Jul 2000 : Column: 573W
Mrs. Virginia Bottomley: To ask the Secretary of State for Health how many NHS (a) state and (b) community in-patient hospital beds were available in (i) the South West Surrey constituency and (ii) the West Surrey health authority in May (1) 1997, (2) 1998, (3) 1999 and (4) 2000. 
|All trusts||Community trusts|
Mrs. Virginia Bottomley: To ask the Secretary of State for Health how many patients had been waiting for in-patient treatment, excluding day cases, for more than one year on 31 March (a) 1997, (b) 1998, (c) 1999 and (d) 2000 in West Surrey health authority. 
|Total number of patients|
|31 March 1997||426|
|31 March 1998||751|
|31 March 1999||675|
|31 March 2000||763|
(3) what research his Department has commissioned since 1970 on the long-term effects of Thorotrast upon patients. 
Ms Stuart [holding answer 5 July 2000]: We are not aware of any advice that this Department has given to health authorities and National Health Service trusts on tracing patients exposed to Thorotrast since 1970.
12 Jul 2000 : Column: 574W
It is not known how many patients were exposed to Thorotrast between 1928 and its discontinuation in 1955 and no estimate of the number of cancers attributable to the use of Thorotrast is available. We are not aware of any formal programme for tracing patients exposed to Thorotrast. It is not known how many people alive today may have been exposed to Thorotrast four to seven decades ago.
Fiona Mactaggart: To ask the Secretary of State for Health how many samples are analysed each week for the purposes of registration as a bone marrow donor by (a) the National Blood Service and (b) voluntary organisations. 
Mr. Denham: The National Blood Service currently types around 120 samples each week. This will rise to 250 each week by the end of 2000-01. We understand that the Anthony Nolan Bone Marrow Trust aims to recruit around 300 new donors a week.
|Next Section||Index||Home Page|